Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) has scheduled the release of its fourth quarter and full year 2024 financial results for Thursday, January 30, 2025, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results.

Participants can join the call by dialing 888-455-0391 (U.S. and Canada) or 773-756-0467 (international) using passcode '7895081'. The earnings release and webcast will be available on Quest's investor website. A replay will be accessible until February 13, 2025, via phone or the company's investor website.

SECAUCUS, N.J., Jan. 2, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report fourth quarter and full year 2024 financial results on Thursday, January 30, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.

The conference call can be accessed by dialing 888-455-0391 within the U.S. and Canada, or 773-756-0467 internationally, using the passcode: "7895081." The earnings release and live webcast will be posted on www.QuestDiagnostics.com/investor. The company suggests participants dial in approximately 10 minutes before the call.

A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-360-8701 for domestic callers or 203-369-0179 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on January 30, 2025 until midnight Eastern Time on February 13, 2025.

Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-january-30-2025-302337581.html

SOURCE Quest Diagnostics

FAQ

When will Quest Diagnostics (DGX) release Q4 and full year 2024 earnings?

Quest Diagnostics will release its Q4 and full year 2024 financial results on Thursday, January 30, 2025, before the market opens.

What time is Quest Diagnostics (DGX) Q4 2024 earnings call?

Quest Diagnostics' Q4 2024 earnings conference call is scheduled for 8:30 a.m. Eastern Time on January 30, 2025.

How can investors access Quest Diagnostics (DGX) Q4 2024 earnings call?

Investors can access the call by dialing 888-455-0391 (U.S./Canada) or 773-756-0467 (international) using passcode '7895081'. A live webcast will also be available on QuestDiagnostics.com/investor.

Until when will Quest Diagnostics (DGX) Q4 2024 earnings call replay be available?

The earnings call replay will be available until midnight Eastern Time on February 13, 2025, through the company's investor website or by phone.